298 related articles for article (PubMed ID: 23030000)
1. Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles.
Lalani J; Raichandani Y; Mathur R; Lalan M; Chutani K; Mishra AK; Misra A
J Biomed Nanotechnol; 2012 Dec; 8(6):918-27. PubMed ID: 23030000
[TBL] [Abstract][Full Text] [Related]
2. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies.
Lalani J; Rathi M; Lalan M; Misra A
Drug Dev Ind Pharm; 2013 Jun; 39(6):854-64. PubMed ID: 22799442
[TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
4. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Chen YC
Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled polymersomes conjugated with lactoferrin as novel drug carrier for brain delivery.
Yu Y; Pang Z; Lu W; Yin Q; Gao H; Jiang X
Pharm Res; 2012 Jan; 29(1):83-96. PubMed ID: 21979908
[TBL] [Abstract][Full Text] [Related]
6. Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
Tahara K; Miyazaki Y; Kawashima Y; Kreuter J; Yamamoto H
Eur J Pharm Biopharm; 2011 Jan; 77(1):84-8. PubMed ID: 21074612
[TBL] [Abstract][Full Text] [Related]
7. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
Mao J; Meng X; Zhao C; Yang Y; Liu G
Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
[TBL] [Abstract][Full Text] [Related]
8. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.
Chang J; Paillard A; Passirani C; Morille M; Benoit JP; Betbeder D; Garcion E
Pharm Res; 2012 Jun; 29(6):1495-505. PubMed ID: 22167349
[TBL] [Abstract][Full Text] [Related]
9. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y
Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
[TBL] [Abstract][Full Text] [Related]
11. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C
J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857
[TBL] [Abstract][Full Text] [Related]
12. Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations.
Chen J; Zhang C; Liu Q; Shao X; Feng C; Shen Y; Zhang Q; Jiang X
J Drug Target; 2012 Feb; 20(2):174-84. PubMed ID: 21992548
[TBL] [Abstract][Full Text] [Related]
13. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
[TBL] [Abstract][Full Text] [Related]
14. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease.
Hu K; Shi Y; Jiang W; Han J; Huang S; Jiang X
Int J Pharm; 2011 Aug; 415(1-2):273-83. PubMed ID: 21651967
[TBL] [Abstract][Full Text] [Related]
16. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Lin PI; Wang CC
Nanomedicine (Lond); 2011 Aug; 6(6):1011-26. PubMed ID: 21707298
[TBL] [Abstract][Full Text] [Related]
17. In vitro schistosomicidal activity of the lignan (-)-6,6'-dinitrohinokinin (DNHK) loaded into poly(lactic-co-glycolic acid) nanoparticles against Schistosoma mansoni.
Lima TC; Lucarini R; Luz PP; de Faria EH; Marçal L; Magalhães LG; Badoco FR; Esperandim VR; Molina EF; Laurentz RS; Lima RG; Cunha WR; Bastos JK; Silva MLA
Pharm Biol; 2017 Dec; 55(1):2270-2276. PubMed ID: 29172838
[TBL] [Abstract][Full Text] [Related]
18. Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats.
Sun D; Xue A; Zhang B; Lou H; Shi H; Zhang X
J Pharm Pharmacol; 2015 Dec; 67(12):1650-62. PubMed ID: 26407669
[TBL] [Abstract][Full Text] [Related]
19. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
20. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A.
Jose S; Sowmya S; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Eur J Pharm Sci; 2014 Oct; 63():29-35. PubMed ID: 25010261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]